-
公开(公告)号:US10744258B1
公开(公告)日:2020-08-18
申请号:US15913729
申请日:2018-03-06
申请人: Qualigen Inc.
发明人: Michael Poirier
摘要: A whole blood treatment device includes a first conduit, a second conduit, and a rotating or reciprocating element having a channel. The first and second conduits are fluidly coupled to the rotating or reciprocating element such that the channel is fluidly continuous with the first conduit when the channel is fluidly discontinuous with the second conduit, and such that the channel is fluidly discontinuous with the first conduit when the channel is fluidly continuous with the second conduit. The first conduit is configured to receive whole blood, and the second conduit is configured to receive a regeneration fluid. The channel comprises a surface that is modified with an affinity agent at a concentration effective to allow removal of a target compound from whole blood.
-
公开(公告)号:US20220143291A1
公开(公告)日:2022-05-12
申请号:US17434107
申请日:2020-02-26
申请人: Qualigen Inc.
发明人: Michael Poirier
摘要: A whole blood treatment device includes a cartridge configured to receive whole blood, having a wall defining an interior volume, an inlet, and an outlet, a support structure having a surface, inside of the cartridge, and an affinity agent, attached to the surface of the support structure. The affinity agent is effective to bind to a target agent that is desirable for removal from a patient. The target agent is selected from the group consisting of: inhibitory checkpoint molecules, inflammatory factors, cancerous cells, autoantibodies, opioids and heavy metals. A method of removing a target agent from whole blood of a patient in a whole blood treatment device comprising pumping whole blood into a cartridge, containing a support structure having a surface, with a plurality of affinity agents on the support structure, to contact the whole blood with the affinity agents; binding the target agent with the affinity agents; and removing the whole blood having a reduced amount of the target agent from the cartridge. The target agent is selected from the group consisting of: inhibitory checkpoint molecules, inflammatory factors, cancerous cells, autoantibodies, opioids and heavy metals.
-
公开(公告)号:US20190126219A1
公开(公告)日:2019-05-02
申请号:US16233772
申请日:2018-12-27
IPC分类号: B01F11/00 , G01N1/44 , G01N35/00 , B01L3/00 , B01L7/00 , C12N15/10 , B01F3/12 , G01N21/64 , C12Q1/6806 , B01F15/00 , G01N21/01 , C12Q1/6844 , B01F13/00
摘要: A receptacle comprises opposed members, a plurality of chambers having perimeter walls defined by seals formed between the opposed members and portals interconnecting the chambers, and a rigid frame supporting the opposed members at their peripheral edges. The frame comprises a front frame portion and a rear frame portion, and the peripheral edges of the opposed members are retained between the front and rear frame portions. An inlet port extends between the front and rear frame portions and is in fluid communication with one of the chambers.
-
公开(公告)号:US20130288348A1
公开(公告)日:2013-10-31
申请号:US13855837
申请日:2013-04-03
发明人: Scott S. Breidenthal , Sara H. Fan , Richard S. Lee , Norman C. Nelson , Matthew J. Scott , Jason A. Taylor
IPC分类号: C12Q1/68
CPC分类号: B01F11/00 , B01F3/1271 , B01F11/0045 , B01F11/0071 , B01F13/0059 , B01F15/00214 , B01F2215/0037 , B01L3/502 , B01L3/502715 , B01L3/50273 , B01L3/502761 , B01L7/52 , B01L7/525 , B01L2200/0621 , B01L2200/0647 , B01L2200/0673 , B01L2200/0689 , B01L2200/10 , B01L2200/14 , B01L2200/16 , B01L2300/0816 , B01L2300/087 , B01L2300/0887 , B01L2300/123 , B01L2300/1805 , B01L2300/1822 , B01L2300/1883 , B01L2400/0457 , B01L2400/0478 , B01L2400/0481 , B01L2400/0655 , B01L2400/0677 , C12N15/1006 , C12Q1/6806 , C12Q1/6844 , G01N1/44 , G01N21/01 , G01N21/6428 , G01N21/645 , G01N35/0098 , G01N2021/6419 , G01N2021/6421 , G01N2021/6432 , G01N2021/6439 , G01N2021/6463 , G01N2035/00544 , G01N2201/0627 , Y10T137/0391 , Y10T436/143333 , Y10T436/25 , Y10T436/255
摘要: A receptacle having a plurality of interconnected chambers arranged to permit multiple process steps or processes to be performed independently or simultaneously. The receptacles are manufactured to separate liquid from dried reagents and to maintain the stability of the dried reagents. An immiscible liquid is included to control loading of process materials, facilitate mixing and reconstitution of dried reagents, limit evaporation, control heating of reaction materials, concentrate solid support materials to prevent clogging of fluid connections, provide minimum volumes for fluid transfers, and to prevent process materials from sticking to chamber surfaces. The receptacles can be adapted for use in systems having a processing instrument that includes an actuator system for selectively moving fluid substances between chambers and a detector. The actuator system can be arranged to concentrate an analyte in a sample. The detector can be used to detect an optical signal emitted by the contents of the receptacle.
摘要翻译: 具有多个互连室的容器,其布置成允许独立地或同时地执行多个工艺步骤或工艺。 制造容器以将液体与干燥试剂分开并保持干燥试剂的稳定性。 包括不混溶的液体以控制加工材料的加载,促进干燥试剂的混合和重构,限制蒸发,控制反应材料的加热,浓缩固体支持材料以防止流体连接堵塞,为流体转移提供最小体积,并防止 工艺材料从粘附到室表面。 插座可以适用于具有处理器具的系统,该处理器具包括用于选择性地移动腔室和检测器之间的流体物质的致动器系统。 致动器系统可以布置成将分析物浓缩在样品中。 检测器可用于检测由容器的内容物发射的光信号。
-
公开(公告)号:US20020052008A1
公开(公告)日:2002-05-02
申请号:US09949314
申请日:2001-09-07
申请人: Qualigen, Inc.
发明人: Vijay Mahant , Byron Doneen
IPC分类号: G01N033/53
CPC分类号: G01N1/34 , G01N33/491 , G01N2001/4016 , Y10T436/25375 , Y10T436/255
摘要: A method of separating a cell-containing sample into a substantially cell-depleted portion, and a cell-containing portion comprising at least one of a stem cell, a lymphocyte, and a leukocyte comprises a step in which the sample is received in a vessel with at least one flexible wall. In another step, an additive and particles are added to the sample, wherein the additive substantially binds to the at least one of the stem cell, lymphocyte, and leukocyte, and the particles and wherein the particles substantially bind to the at least one of the stem cell, lymphocyte, and leukocyte, and the additive, thereby producing a cell-containing network. In a further step, the network is separated from the substantially cell-depleted portion by applying a magnetic force.
摘要翻译: 将含有细胞的样品分离成基本上细胞贫乏的部分的方法和包含干细胞,淋巴细胞和白细胞中的至少一种的含细胞部分包括将样品容纳在容器中的步骤 至少有一个柔性墙。 在另一步骤中,向样品中加入添加剂和颗粒,其中所述添加剂基本上结合至干细胞,淋巴细胞和白细胞中的至少一种,以及所述颗粒,并且其中所述颗粒基本上结合至所述至少一种 干细胞,淋巴细胞和白细胞,以及添加剂,从而产生含细胞的网络。 在另一步骤中,通过施加磁力将网络与基本上细胞耗尽的部分分离。
-
公开(公告)号:USD979073S1
公开(公告)日:2023-02-21
申请号:US29833681
申请日:2022-04-06
申请人: Qualigen Inc.
设计人: Michael Poirier
-
公开(公告)号:USD952157S1
公开(公告)日:2022-05-17
申请号:US29738845
申请日:2020-06-19
申请人: Qualigen Inc.
设计人: Michael Poirier
-
公开(公告)号:US11235295B2
公开(公告)日:2022-02-01
申请号:US16233927
申请日:2018-12-27
IPC分类号: B01L3/00 , B01F11/00 , B01F13/00 , B01L7/00 , G01N21/64 , B01F15/00 , G01N21/01 , C12Q1/6844 , G01N1/44 , G01N35/00 , C12N15/10 , B01F3/12 , C12Q1/6806
摘要: A method of processing a sample in a receptacle comprising a plurality of chambers. Each of the chambers is connected to at least one other chamber by a portal and at least a first one of the chambers is formed of a flexible material. The method includes the steps of causing gas bubbles contained in the first chamber to accumulate in a portion of the first chamber, applying a compressive external force to the first chamber to cause some or all of the liquid contents of the first chamber to flow into an interconnected second chamber through a portal connecting the first and second chambers; and preventing the gas bubbles accumulated in a portion of the first chamber from flowing through the portal into the second chamber.
-
公开(公告)号:US20170219466A1
公开(公告)日:2017-08-03
申请号:US15493061
申请日:2017-04-20
申请人: Qualigen, Inc.
CPC分类号: G01N1/4005 , B01D69/02 , B01D2319/06 , B01D2325/36 , B01D2325/38 , G01N33/491
摘要: Devices and methods are presented in which a plasma separation device with a first and second portion separates a blood containing fluid. Most preferably, the first portion produces a cell fraction and a plasma fraction, and the second portion captures the plasma fraction. A first actuator then fluidly isolates a portion of the plasma fraction within the second portion, and a second actuator moves the isolated portion of the plasma fraction from the second portion.
-
公开(公告)号:US10688458B2
公开(公告)日:2020-06-23
申请号:US15485330
申请日:2017-04-12
IPC分类号: B01L3/00 , B01F11/00 , B01F13/00 , B01L7/00 , G01N21/64 , B01F15/00 , G01N21/01 , C12Q1/6844 , G01N35/00 , C12N15/10 , B01F3/12 , C12Q1/6806
摘要: A receptacle having a plurality of interconnected chambers arranged to permit multiple process steps or processes to be performed independently or simultaneously. The receptacles are manufactured to separate liquid from dried reagents and to maintain the stability of the dried reagents. An immiscible liquid, such as an oil, is included to control loading of process materials, facilitate mixing and reconstitution of dried reagents, limit evaporation, control heating of reaction materials, concentrate solid support materials to prevent clogging of fluid connections, provide minimum volumes for fluid transfers, and to prevent process materials from sticking to chamber surfaces. The receptacles can be adapted for use in systems having a processing instrument that includes an actuator system for selectively moving fluid substances between chambers and a detector. The actuator system can be arranged to concentrate an analyte present in a sample. The detector can be used to detect an optical signal emitted by the contents of the receptacle.
-
-
-
-
-
-
-
-
-